Premium
Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease
Author(s) -
Okun Michael S.,
Lang Anthony,
Jankovic Joseph
Publication year - 2010
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.23021
Subject(s) - neurology , movement disorders , medicine , psychology , gerontology , library science , family medicine , disease , psychiatry , computer science